首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1810篇
  免费   118篇
  国内免费   3篇
耳鼻咽喉   49篇
儿科学   99篇
妇产科学   17篇
基础医学   328篇
口腔科学   46篇
临床医学   169篇
内科学   311篇
皮肤病学   28篇
神经病学   122篇
特种医学   106篇
外国民族医学   2篇
外科学   219篇
综合类   22篇
预防医学   127篇
眼科学   16篇
药学   168篇
中国医学   1篇
肿瘤学   101篇
  2023年   8篇
  2020年   16篇
  2019年   18篇
  2018年   24篇
  2017年   28篇
  2016年   24篇
  2015年   40篇
  2014年   42篇
  2013年   59篇
  2012年   76篇
  2011年   71篇
  2010年   75篇
  2009年   55篇
  2008年   64篇
  2007年   65篇
  2006年   66篇
  2005年   54篇
  2004年   64篇
  2003年   53篇
  2002年   65篇
  2001年   51篇
  2000年   29篇
  1999年   41篇
  1998年   35篇
  1997年   40篇
  1996年   36篇
  1995年   39篇
  1994年   31篇
  1993年   43篇
  1992年   34篇
  1991年   28篇
  1990年   38篇
  1989年   37篇
  1988年   46篇
  1987年   37篇
  1986年   37篇
  1985年   31篇
  1984年   16篇
  1983年   18篇
  1982年   10篇
  1981年   19篇
  1979年   12篇
  1978年   15篇
  1976年   15篇
  1975年   8篇
  1974年   10篇
  1970年   10篇
  1876年   8篇
  1872年   9篇
  1868年   8篇
排序方式: 共有1931条查询结果,搜索用时 821 毫秒
1.
2.
Cidofovir is an acyclic nucleoside phosphonate with broad-spectrum activity against DNA viruses, including human papilloma virus (HPV). However, data on the efficacy of cidofovir in an immunosuppressive setting remain contradictory. We report for the first time on the promotion of the healing of recalcitrant warts in a patient with myelodysplastic syndrome with intravenous cidofovir treatment.  相似文献   
3.
4.
Summary In 1981 generalized anaphylaxis was registered on 166 occasions in Dutch general and academic hospitals. Clinical details of 120 of those patients revealed that in 107 anaphylaxis was either probable (n=90) or possible (n=17), whereas in 13 cases some other reaction than anaphylaxis had occurred. The series of confirmed cases contained 46 men and 61 women, with mean ages of 47 y and 48 y, respectively.There was a complete recovery in 102 patients and two patients died. Hypotension was present in 79 cases (74%), dyspnoea in 34 cases (32%) and a skin reaction, mainly urticaria, erythema or angioedema, was mentioned in 62 cases (58%). Most cases of anaphylaxis were drug-induced (76%), the main causes being the analgesic glafenine and contrast media. Glafenine was mentioned as the cause in 36% of all admissions for drug-induced anaphylaxis. Only 3.7% of cases had been reported to the voluntary reporting scheme of the Netherlands Centre for Monitoring of Adverse Reactions to Drugs.On the basis of reimbursement data, the risk of developing severe anaphylaxis to glafenine was estimated at 11.7–19.3-fold relative to indomethacin, and 13.4–20.2-fold relative to oral penicillins.  相似文献   
5.
6.
7.
Ohne ZusammenfassungEin Charakterbild aus der Geschichte der Medicin.  相似文献   
8.
9.
There are several reports on cardiac adverse reactions attributed to the antimigraine drug sumatriptan in the recent literature. In order to assess the frequency and the character of adverse reactions to sumatriptan, a postmarketing cohort study was performed one year after registration of the drug in The Netherlands. With assistance of 86% of the drug dispensing general practitioners in The Netherlands, 1727 patients who had received sumatriptan were traced in July, 1992. Via their general practitioners, a questionnaire about use of sumatriptan, adverse reactions and other medication was sent to the patients in December 1992. During the study period, seven patients were lost to follow-up. Of the 1720 remaining patients, 1202 (70%) responded to the questionnaire, of whom 1187 had actually used sumatriptan. The most frequently reported suspected adverse reactions were paraesthesiae (139 patients, 95% CI 9.9%–13.5%) and dizziness (96 patients, 95% CI 6.5%–9.7%). Chest pain after use of sumatriptan was reported by 94 patients (7.9%, 95% CI 6.4%–9.4%), and according to the close temporal relationship with the intake of sumatriptan and a positive rechallenge, a causal relationship was probable in most of those patients. The frequency of chest pain attributed to sumatriptan was higher in females (9.0% vs 4.6%; relative risk 1.9, 95% CI 1.1–3.4). Age and hypertension were not associated with chest pain attributed to sumatriptan. Dyspnoea attributed to sumatriptan was reported by 26 patients (2.2%), and was associated with obstructive lung disease (relative risk 5.4 95% CI 1.7–16.9). Thus, in view of the high frequency of chest pain after use of sumatriptan and reports in the literature of cardiac disturbances, including myocardial infarction, cautious use of the drug is advised.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号